GUBBA PHARMA IN E NEWS

Read More

BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form

BDR Pharmaceuticals said it has introduced Enzalutamide oral solution for treatment of prostate cancer, claiming to be the first company in the world to bring...

Continue Reading

Read More

Sun Pharma acquires Israel’s Libra Merger

Drugmaker Sun Pharmaceutical Industries has acquired 100 per cent shares of Libra Merger Ltd, a company incorporated in Israel.This is Sun’s second buy in Israel,...

Continue Reading

Read More

IIL setting up animal vax facility in Genome Valley

Biotech player Indian Immunologicals Limited (IIL) is setting up a greenfield veterinary vaccines manufacturing facility in Genome Valley, Hyderabad, at an investment of 700 crore.The...

Continue Reading

Read More

Biocon jumps after inking deal with Sandos for distribution of FKB injection in Japan

Biocon shares jumped in morning deals on BSE in the first trading session after the company signed an agreement with Sandoz for the distribution of...

Continue Reading

Read More

Lupin launches Softovac Liquifibre

LupinLife, the consumer healthcare business of Lupin has announced the launch of Softovac Liquifibre, Ayurvedic liquid laxative.With this, the company enters the Indian liquid laxative...

Continue Reading

Read More

Cipla ups investment in GoApptiv, its third in the digi-tech company

Drugmaker Cipla has agreed to invest Rs 42 crore in digi-tech company GoApptiv Private Limited, in line with its strategy to invest in “channels of...

Continue Reading

Read More

Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 million

Pharma major Sun Pharmaceutical informed that it has entered into an agreement to acquire 16.7 per cent stake in the US-based Lyndra Therapeutics for $30...

Continue Reading

Read More

Lupin introduces triple combination Vilfuro-G in India for COPD

Pharmaceutical company Lupin has introduced the fixed-dose triple combination (FDC) drug, Vilfuro-G, to manage chronic obstructive pulmonary disease (COPD) in India.Lupin’s Vilfuro-G blends fluticasone furoate,...

Continue Reading

Read More

Dr. Reddy’s becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index

Dr. Reddy’s has become the first Indian pharma company to earn a place in the Standard & Poor Dow Jones Sustainability World Index (DJSI World)...

Continue Reading